Published on 08/12/2025

Sampling Strategies: Stratified, Time-Based, and Risk-Based

In the rapidly evolving domain of AI/ML within Good Practice (GxP) analytics, robust validation methodologies are essential for ensuring compliance with regulatory requirements, particularly concerning intended use risk, data readiness curation, and bias and fairness testing. As organizations strive to implement effective ai ml model validation processes, sampling strategies play a critical role. This tutorial will explore stratified, time-based, and risk-based sampling strategies in the context of ai ml model validation, providing professionals with a comprehensive guide to best practices and methodologies.

Understanding Sampling Strategies in AI/ML Model Validation

Sampling strategies refer to the methods used to select a subset of data for testing and validation purposes in model development. Given the complexities involved in AI/ML analytics, particularly in pharmaceutical applications, it is crucial to employ sampling techniques that can provide representative data sets while minimizing bias and ensuring compliance with standards such as Part 11 of Title 21 of the Code of Federal Regulations and Annex 11 of the European Union’s guidelines. This section focuses on the fundamental concepts of sampling strategies.

1. Importance of Sampling in Model Validation

Sampling is a cornerstone of statistical analysis; it allows professionals to ensure the reliability and robustness of AI/ML models. In model verification and validation, the quality of the results can significantly affect decision-making in clinical operations. Thus, understanding the various sampling strategies enhances the accuracy of validation activities.

2. Types of Sampling Strategies

• Stratified Sampling: This method involves dividing the data into different subgroups (strata) and ensuring that each subgroup is adequately represented in the sample, which is crucial for reducing bias.
• Time-Based Sampling: This approach uses data collected over a specific period, ensuring that various time frames are considered to analyze trends and performance stability.
• Risk-Based Sampling: Prioritizes the testing focus based on potential impacts and risks associated with model outputs, ensuring that critical failure points are addressed efficiently.

Implementing Stratified Sampling in AI/ML Model Validation

Stratified sampling is particularly valuable in situations where the data set is heterogeneous, meaning it comprises distinct subgroups that could result in varied model performance. This section outlines a step-by-step guideline to implement a stratified sampling approach effectively.

Step 1: Define the Strata

Identify the characteristics of your data that are relevant to the model. You may categorize data based on demographics, geographic considerations, or other pertinent criteria to your validation needs. This is essential to ensure that all subgroups are represented proportionately.

Step 2: Determine Sample Size

The sample size should be calculated based on the total population within each stratum. Statistical methods, such as power analysis, can help determine the appropriate size necessary to achieve statistically significant results.

Step 3: Collect Data

Gather data from each stratum, ensuring that the sampling method chosen (random or systematic) is employed uniformly across all categories. This helps in maintaining integrity and eliminating bias.

Step 4: Validate the Sample

Once your samples are collected, validate them against the intended use parameters of the model. Here, aspects such as data readiness curation and bias and fairness testing should be meticulously evaluated to ensure the samples reflect real-world scenarios accurately.

Step 5: Analyze and Interpret Results

Upon completing the stratified sampling, analyze the results against your model’s intended use. The findings should be documented in detail, maintaining compliance with both documentation and audit trails requirements.

Utilizing Time-Based Sampling for AI/ML Models

Time-based sampling is crucial for understanding the model’s performance across different periods, particularly in environments where external conditions may vary over time. This section presents a structured approach to implementing time-based sampling.

Step 1: Define Time Intervals

Establish the time intervals during which data will be collected. This could be daily, weekly, monthly, or any other interval relevant to your analysis. Ensure the intervals capture significant variations that could affect outcomes.

Step 2: Collect Temporal Data

Gather data within each predefined time interval. Time-based sampling often demands special attention to trends and seasonality which may impact the stability of model performance across the selected timeframe.

Step 3: Address Data Drift

One of the significant challenges in time-based sampling is data drift. Conduct drift monitoring regularly to assess whether the model’s performance is degrading over time. If drift is detected, consider implementing re-validation or adjustments to the model.

Step 4: Evaluate Outcomes

As data is collected over time, continuously evaluate the model’s performance using established metrics. This helps in distinguishing normal variations from significant deviations that might indicate a need for model updates.

Step 5: Document Findings

Document your analyses, results, and subsequent decisions to align with regulations regarding audit trails and validation records. Compliance with guidelines, especially 21 CFR Part 11, is paramount in maintaining the integrity of your validation processes.

Implementing Risk-Based Sampling for AI/ML Model Validation

Risk-based sampling emphasizes directing resources toward validating the components of AI/ML models that pose the greatest risk. In the pharmaceuticals sector, this may involve prioritizing features that could impact patient safety or regulatory compliance significantly. Below are the steps to effectively apply risk-based sampling.

Step 1: Conduct a Risk Assessment

Begin by identifying and assessing risks associated with different outputs of the AI/ML model. This includes considering potential failure modes, their impact, and likelihood. Using tools such as Failure Mode and Effects Analysis (FMEA) can be beneficial.

Step 2: Prioritize Validation Efforts

Based on the risk assessment, prioritize which components of the model warrant detailed validation efforts. Higher-risk aspects might need more comprehensive testing compared to lower-risk features.

Step 3: Develop Sampling Plan

Create a sampling plan based on the validated risk assessments. This plan should dictate the ratio of samples to be drawn from high-risk vs. low-risk categories, reflecting the potential impact of each segment.

Step 4: Execute Testing

Conduct the sampling and testing as per the established plan. Ensure that validation tests are robust and adequately measure performance under various conditions, including edge cases and worst-case scenarios.

Step 5: Continuous Monitoring and Re-Validation

Risk assessment is an ongoing process, hence continuous monitoring is essential. Regular check-ins to re-evaluate risk levels and the documentation of outcomes guide decisions regarding model adjustments or retraining when necessary.

Documentation and Audit Trails in AI/ML Model Validation

Documentation and maintaining audit trails are critical components in the validation of AI/ML models, especially within cGMP environments. This section discusses best practices for documentation in the context of the aforementioned sampling strategies.

1. Importance of Documentation

Maintaining comprehensive documentation serves multiple purposes: it provides evidence of compliance with regulatory standards, supports organizational knowledge management, and enables backtracking during audits or inspections.

2. Key Documentation Elements

• Validation Plans: Clearly outline methodology, sampling strategies implemented, and verification steps.
• Results Reports: Include data, analyses performed, and interpretations drawn from the results, detailing how the sampling strategy influenced these outcomes.
• Change Controls: Document any changes to the model or processes, along with justifications and impacts on validation efforts.

3. Maintaining An Audit Trail

A comprehensive audit trail captures all actions taken during model development, validation, and updates, ensuring that all adjustments can be traced back and justified. This is particularly important for compliance with regulations such as 21 CFR Part 11 and Annex 11.

Governance and Security in AI/ML Model Validation

AI governance and security are paramount to ensuring the integrity of models used within pharmaceutical settings. Governance frameworks help in establishing accountability and setting policies regarding model usage, compliance, and data management.

1. Establishing an AI Governance Framework

Before implementing AI/ML models, organizations should establish a robust governance framework that outlines roles, responsibilities, and risk management approaches. This framework must ensure model compliance with regulatory requirements and internal standards.

2. Security Best Practices

• Data Security: Protect sensitive data utilized in model development. Implement data encryption, access controls, and regular security assessments to mitigate risks.
• Compliance Monitoring: Regularly audit AI/ML model applications against compliance standards to ensure adherence to relevant regulations.
• Model Explainability: Leverage explainable AI (XAI) techniques to provide insights into how decisions are made by AI models, enhancing transparency and compliance with regulatory expectations.

3. Continuous Improvement

Finally, treat AI model validation as an iterative process, emphasizing continuous improvement. Regular updates to governance structures, security practices, and validation methodologies will ensure that the organization’s practices evolve with advancements in technology and regulatory expectations.

Conclusion

In summary, effective AI/ML model validation within the pharmaceutical landscape requires comprehensive sampling strategies that address stratified, time-based, and risk-based approaches. By meticulously documenting processes, adhering to audit trail requirements, and establishing robust governance and security frameworks, pharmaceutical professionals can ensure compliance with US FDA, EMA, MHRA, and PIC/S standards. As the regulatory landscape continues to evolve, maintaining flexibility and openness to innovative sampling strategies will be key to staying ahead in the dynamic world of AI/ML analytics in GxP environments.